Mubasher TV
Contact Us Advertising   العربية

Glaxo Smith Kline (BIOC)

Last update: 01:14 PM market time.
43.02
0.43
1.01%
Open 42.59
Previous Close 42.59
High 43.50
Low 42.60
Stock Statistics
Volume 42,619
Turnover 1,832,076.50
All data are 15 minutes late during market session

General Information

Company Name Glaxo Smith Kline (BIOC)
Company Purpose Glaxo SmithKline is a public company, listed on Egyptian Exchange (EGX) since October 1985. It operates within the Pharmaceuticals, Biotechnology and Life Sciences sector focusing on Pharmaceuticals. Glaxo SmithKline is based in Cairo, Egypt and was established in January 1981.
Company Establish Date 14 January 1981
Financial Year Start First Quarter
Auditor
  • Baker Tilly - Wahid Abdel Ghaffar and Co
  • Wafiq Alfred Hanna

Ownership

  • Glaxo Group Ltd (91.20%)
  • Qatar National Bank (5.89%)

Management

Ahmed Abdel Hamid Fahmy Khattab Chairman Represents Glaxo Group Ltd
Hassan Mahmoud Hassan Mahmoud Fahmy Managing director Represents Glaxo Group Ltd
Munir Ghabbour Hanna Board Members
Shirin Al Ansary Board Members Represents Qatar National Bank
Omnia Saad Abd El Rahman Kelig Board Members
Laila Daniel Shaker Boles Board Members Represents Glaxo Group Ltd
Mohammad Ali Abdul Azim Board Members Represents Glaxo Group Ltd
Vikas Jan Board Members Represents Glaxo Group Ltd
Omar Sameh Shoukry Board Members Represents Glaxo Group Ltd

Subsidiaries

  • Amoun Pharmaceutical Industries (99.64%)
  • Modern Pharma International (20.00%)

Contacts

Address Boomerang Buliding, New Cairo, Cairo, P.O. Box 41.
Phone +20 2 26185000
Fax +20 2 26185001
Contact Person Omar Sameh Shoukry